Figure 3From: Effectiveness of low-dose doxycycline (LDD) on clinical symptoms of Sjögren's Syndrome: a randomized, double-blind, placebo controlled cross-over studyVAS scores of measured subjective symptoms in weeks one and seven. * indicates statistically significant differences between the observation time points (p < 0.05; Wilcoxon signed test).Back to article page